πŸ”¬Deep Research

QGEN β€” Qiagen Β· catalysts, narrative & risks

Β·28 sourcesQGEN forecast β†’

Qiagen (QGEN) β€” Point-in-Time Research Note (as of 2026-10-04)

Snapshot. Qiagen N.V. trades on the NYSE under ticker QGEN (ISIN NL0015002SN0). As of October 2, 2026 the share traded around $45.29 intraday (up ~7.7% on the day) per [1], or roughly $44.75 at the Oct 2 close (up ~6.45%), implying a market capitalization of about $9.2–9.3 billion [1], [14]. The two sources report slightly different intraday vs. closing figures. Classification varies by source β€” diagnostics/research [1], biotechnology [21] β€” though the internal universe file lists it under healthcare_services.

Recent Catalysts (July–October 2026)


AI-assisted research from the K3vl4r desk β€” not personalized investment advice. More research β†’